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Abstract 
Effects of cocaine on HIV-1 with regard to histone methylation and T-cell 
adhesion 
Jasmine Shirazi 
 
Drug abuse has been shown to cause epigenetic changes in brain tissue that have been 
shown to play roles in addictive behaviors, while also increasing the transmigration of 
immune cells through the blood-brain barrier (BBB).  In conjunction with HIV-1 
infection, it can cause epigenetic changes at the viral promoter that can result in altered 
gene expression, and exacerbate disease progression overall. Given the importance of 
chromatin remodeling in controlling the retroviral promoter (long terminal repeat, LTR), 
and the high susceptibility of the drug abusing population to HIV infection, it would be 
beneficial to understand the way in which the host genome is modified and regulated by 
drugs of abuse. The effect that cocaine has on histone methylation, specifically Histone 3 
Lysine 9 di/tri-methylation, Histone 3 Lysine 27 di-methylation, and Histone 3 Lysine 79 
di-methylation, on the long terminal repeat (LTR) is explored. An increase in histone 
modifications that would suppress gene expression was observed. Furthermore, cocaine 
use is known to cause increase immune cell invasion in the central nervous system, 
contributing to the neuroAIDS. A flow chamber was constructed for use in a laminar 
flow assay in with the intention of investigating the effects of cocaine on T-cell adhesion 
to the BBB.  
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Chapter 1: Literature Review 
 
Introduction 
Drug abuse is a prevalent public health problem in the United States, affecting the 
abusing individuals as well as their families and the community at large. Surveys taken 
from 2010 to 2011 showed that roughly 12.6% of Americans over the age of twelve 
reported using marijuana in the past year and that 4.6% of Americans between the ages of 
18 and 25 reported cocaine use in the past year (1). Additionally, drug abuse and 
addiction, excluding alcohol and tobacco, cost the United States approximately $181 
billion per year in health care and loss of productivity due to crime and other factors (2).   
 Drugs of abuse such as cannabinoids, opioids, and cocaine are known to produce 
numerous physical effects, including addiction. While they can cause seemingly benign 
symptoms such as euphoria and heightened sensations, they can also lead to harmful 
long-term effects, especially in terms of cognitive function, such as physical dependence, 
withdrawal, neurological changes, organ damage (3), and even epigenetic changes (4). 
Cannabinoids, opiates, and cocaine differ in their mechanisms of action, but are all 
known to produce deleterious effects on the immune system, often by causing an 
imbalance in the Th1 pro-inflammatory and Th2 anti-inflammatory cytokines, leading to 
greater susceptibility to infection (5). 
 Illegal drug use is considered the second most common route of human 
immunodeficiency virus type 1 (HIV-1) infection (6), occurring via sharing of needles 
and unsafe sexual intercourse, and continued abuse has also been found to impact the 
progression of the disease. Additionally, exposure of an individual to drugs of abuse, 
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viral infection, and a multitude of other factors can result in epigenetic modifications to 
their genes and integrated viral genes, prompting further study into the interaction 
between these pathologies. The relationship between cannabis, opioids, and cocaine, 
three common drugs of abuse that share a high correlation with HIV-1 infection (7), and 
HIV-1 gene expression and epigenetics will be explored in this review.   
Epigenetics are the chemical and physical code written over our genome’s DNA 
sequences that involve the regulation of gene expression without any changes to the DNA 
sequence itself. Rather the factors “above the genome” are modified in a way that results 
in phenotype plasticity, oftentimes lineage commitment, and can be inherited from one 
daughter cell to the next through generations of a family (8). One of the primary 
components of epigenetics is chromatin accessibility. Chromatin and its components, 
nucleosomes and histones, help to condense DNA and are critically important in gene 
regulatory control and to ensure correct gene expression (9).  It can be categorized into 
euchromatin, which consists of regions of active, accessible chromatin, and 
heterochromatin, which consists of inactive, condensed chromatin. Each type of 
chromatin has its own markers based on the methylation of its DNA and acetylation 
patterns of its histones (Fig. 1.1).   
DNA methylation, which occurs on the cytosine residue of CpG dinucleotides in the 
5’ regulatory regions of DNA, is an important epigenetic alteration that can result in 
silenced genes (10).  During DNA methylation, a methyl group is added to the 5 position, 
known as C5, of cytosine residues by DNA methyltransferases (DNMTs). This leads to a 
repression in gene transcription through recruitment of co-repressor complexes such as 
histone deacetylases (HDACs) and DNA methyl-binding domain proteins (MBDs) (11). 
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Methyl-CpG-binding protein 2 (MeCP2) recruits HDACs to methylated DNA, resulting 
in the removal of acetyl groups from the histones, and therefore prevents transcription 
(12).  
The acetylation of histones is carried out by several histone-modifying enzymes, 
namely histone acetyltransferases (HATs).  There is a clear link between histone 
acetylation and chromatin remodeling, an ATP-dependent process in which a remodeling 
complex disrupts the contact between the DNA and the histones by altering its rotational 
phasing, allowing DNA-binding proteins to access the DNA (13). SWI/SNF is one of the 
widely studied remodeling complexes, which contains a bromodomain in the C-terminal 
region that is attracted to the histones’ acetylated lysines (Step C) (14). While the 
mechanism by which the complex remodels chromatin is still being explored, it is 
believed that remodeler ATPases anchor the nucleosome while an ATPase domain 
involved in translocation binds to the DNA. This ATPase/translocase domain then pulls 
DNA from the linker towards the histones (Step C1), leaving a loop of DNA around the 
nucleosome (Step C2). The transient DNA loop disseminates around the nucleosome and 
disrupts the histone-DNA contacts, eventually replacing them on the edge of the loop 
(Step C3) (15). This process results in nucleosome repositioning leaving the DNA 
sequences accessible for transcription (16, 17).  
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Fig. 1.1. Steps involved in histone modifications. (A) The HAT is recruited by a 
specific DNA sequence and acetylates the histone tails. (B) The bromodomain in the 
SWI/SNF complex is attracted to the acetylated histone tails. The complex then disrupts 
the DNA’s rotational phasing, altering the contact between the DNA and the histone. (C) 
(1) ATPase/translocase binds to the DNA, (2) pulling the linker DNA towards the 
histone. (3) This forms a DNA loop that spreads through the DNA strand. (D) TFIID is 
able to bind to the promoter. This results in bending of the DNA strand, causing the 
modified nucleosome to slide to the next position. 
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Epigenetic changes are especially important during infection with retroviruses, such 
as human T-cell leukemia virus type 1 (HTLV-1) and HIV-1, because they remain 
integrated in the host’s genome. The activity of both the HTLV-1 and HIV-1 promoters, 
called long terminal repeat (LTR) are affected by epigenetic changes.  The processes of 
viral attachment to a susceptible cell, uncoating, reverse transcription, and integration for 
HIV-1 and HTLV-1 are similar in that once they bind to a susceptible cell and the RNA 
virus is released into the cytoplasm, reverse transcriptase acts to convert the RNA virus 
into a DNA provirus.  These proviruses, like eukaryotic DNA, are coiled with histone 
proteins to form a nucleosome (18), and are packaged in a pre-integration complex 
consisting of integrase, host and viral proteins and transcription factors, and thus is 
capable of functioning as a surrogate cellular transcriptional unit (9).  
 Gene expression following proviral integration is a crucial stage in the viral life 
cycle, which depends on the transactivating proteins Tax in the case of HTLV-1 (19, 20), 
or Tat in the case of HIV-1, and specific transcription factors (TFs) (21, 22). Studies by 
others and us highlight the importance of cellular TFs in Tat- or Tax-mediated LTR 
activation (23-28) (29), and the ability of Tat/ Tax to interact with these factors 
independently (30-33) (34) (35) (36). Further, the review by Aliya et al., (37) provides a 
comprehensive account of the epigenetics of HTLV-1 infection, however, thus far there is 
no report about the effect of any drugs of abuse on HTLV-1 promoter; therefore, we will 
base our discussion on the HIV-1 LTR (38, 39), which is known to be affected by drugs 
of abuse (40, 41). We will also elaborate on the epigenetic effects among overlapping 
populations of virus infected- and individual-drug abusers. 
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Epigenetics of HIV-1 infection 
The integration of HIV-1 into the host’s genome is controlled by several epigenetic 
factors, and therefore is more likely to occur in active transcription units (42). Histone 3 
(H3) acetylation, H4 acetylation, and H3 K4 methylation have been shown to result in 
higher instances of HIV-1 integration, while H3 K27 tri-methylation and DNA CpG 
methylation prevent integration through transcription inhibition. However, further 
investigation into the biochemistry of these phenomena is needed (6). 
 As stated previously, once integrated, HIV-1 can remain transcriptionally quiescent 
in the host’s resting CD4+ cells during highly active anti-retroviral therapy (HAART), 
preventing the virus from being fully eliminated from this reservoir. This latent stage is 
achieved through transcriptional shutdown and the formation of restrictive chromatin at 
the LTR. The transcription initiation factor NF-κB is necessary to reactivate HIV-1, 
although other methods have been discovered (reviewed in (9)). CpG methylation of the 
viral promoter at the 5’ LTR is known to silence many retroviruses, such as HIV-1 (43).  
Briefly, in HIV-1, MBD2 is recruited to the methylated CpG island on the promoter, 
which aids in transcriptional silencing through the recruitment of other factors, such as 
the nucleosome remodeling and histone deacetylation (NuRD) complex. Blocking 
methylation results in decreased recruitment of MBD2 and HDAC2, and thus, greater 
gene expression. Selective hypermethylation observed in CpG sites of the 5’ LTR implies 
that these sites are involved in activation and deactivation of the virus (43).  While 
demethylation of the 5’ LTR has been observed at specific CpG sites during tumor 
necrosis factor-α (TNF-α)-induced reactivation, CpG methylation at 3’ LTR remains 
unaffected in presence of TNF-α (44). Therefore, CpG methylation at specific sites on the 
LTR helps the virus maintain its latency by hindering its reactivation (45) and potentially 
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inducing viral latency (6). This understanding has lead to the use of a DNA 
methyltransferase inhibitor, 5-aza-2’deoxycytidine, that interacts with TNF-α thereby 
allowing reactivation of latent HIV and increasing viral clearance during highly active 
antiretroviral therapy (35). 
 Important epigenetic changes occur during the virus’s integration into the host 
genome as a result of the chromatin remodeling that occurs in order to facilitate the 
efficient viral transcript production of RNA Polymerase II (46). Access to the LTR is 
controlled by five nucleosomes, nuc-0 to nuc-4, located on the 5’ LTR that help to 
regulate gene expression of the virus.  In a condensed chromatin state, nucleosome-1 
(nuc-1), located at the -2 to +140 position, inhibits the promoter when HIV-1 is silent. 
Therefore, it is necessary for the nucleosome to be remodeled before transcription can 
occur. There exists a nucleosome-free region from -255 to -3, which is extended in the 
presence of TNF-α and certain HDAC inhibitors. This is further shown by the histone 
acetylation that occurs at nucleosome-1 when treated with Trichostatin A (TSA), a 
histone deacetylase inhibitor (46).  
 Another mechanism by which HIV-1 maintains latency within host cells is through 
the actions of HDACs. HDACs are recruited to the LTR by cellular DNA binding 
proteins and are then able to deacetylate lysine residues of core histones, repressing 
transcription through this covalent modification. Transcriptionally inactive proviruses are 
also more likely to contain the histone methyltransferase Suv39H1, histone H3 
methylated on K9, repressive heterochromatin protein 1 (HP1) proteins, HP1-α (a 
methylated histone binding protein), and tri-methylated histone H3 with modification on 
lysines 9 and 27. Suv39H1 also interacts with COUP-TF interacting protein 2 (CTIP2) to 
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increase H3K9 methylation (47). In addition, CTIP2 aids in the recruitment of a 
chromatin-modifying complex that leaves the promoter in a heterochromatic state within 
microglial cells, preventing viral transcription. This occurs through interaction with the 
transcription factor, Sp1, and with Tat, a viral trans-activator protein that is then relocated 
to the areas of the chromatin that are transcriptionally inactive. The aforementioned 
epigenetic changes are thought to block the initiation of HIV transcription, stopping the 
Tat-mediated regulatory circuit (48).   
 There are regulatory nucleosomes situated around the HIV transcription start site 
(TSS) that are acetylated when the promoter is activated. While Tat recruits ATP-
dependent chromatin remodeling complexes and HATs to the LTR when the virus is 
active, the chromatin serves as a barrier to polymerase progression in the latent state. 
Latent infection is often observed when the provirus is integrated into regions that are 
rich in heterochromatin. Examples include proviruses that are integrated into centromeric 
alphoid repeats or gene deserts (42). Silent HIV promoters are also found in the presence 
of HDACs, heterochromatin proteins, CpG methylation, and methyltransferases, further 
proving the effect that epigenetic factors have on HIV expression. In fact, latent HIV has 
a tendency to be depressed in the absence of cotranscriptional chromatin reassembly 
factors (CRFs). The absence of CRFs results in greater chromatin accessibility due to 
inadequate nucleosome architecture (49). 
The HIV LTR is generally located in a strategic position relative to certain regulatory 
elements. The virus has been found to preferentially integrate into euchromatic regions 
where genes are transcriptionally active (42), allowing for greater accessibility to 
necessary transcription factors prior to tat-mediated transcription and RNA polymerase. 
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The integrated viral genome is subject to the same regulatory controls that effect human 
genes and therefore, if the HIV-1 promoter is activated, the nucleosomes associated with 
the LTR are quickly disrupted allowing the necessary factors access to the LTR, and vice 
versa when the promoter is silenced.   One region of the LTR promoter that binds to the 
transcription factor, USF, tends not to contain any nucleosomes despite the fact that 
nucleosomes would be able to fit in that space. This is most likely due to the presence of 
USF, which is known to cause promoter bending. The DNA bending leaves the region 
inhospitable to nucleosomes (50).  
 Exposure to drugs that prevent HDAC activity results in viral activation due to the 
resulting increase in histone acetylation, illustrating the extent to which epigenetic effects 
dictate the lifecycle of the virus. 
 
Epigenetics of drug abuse and its impact on HIV-1 infection 
 
As the lifespan of the average HIV-sufferer increases, so does the prevalence of HIV-
associated neurocognitive disorders (HAND). They are believed to be caused by the 
secretion of viral proteins that interact with neurons or by the tendency of infected glia to 
secrete inflammatory molecules (51). Given the fact that drug abuse is known to cause an 
increase in the incidence of these symptoms (51), it would be worth considering whether 
or not these drugs are causing an increase in the neurons’ susceptibility to the disease or 
the immune cells’ tendency to release inflammatory factors in the brain. In addition to 
impact of infection at the gene level, drug addiction is in itself responsible for epigenetic 
changes that involve transcriptional irregularities, such as overexpression of ΔFOSB in 
the brain reward regions, rendering individuals more prone to drug addiction and 
modifying neuronal plasticity (11, 52). Drug addiction is also believed to activate the 
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brain’s reward circuitry, with greater dopaminergic transmission between the ventral 
tegmental area (VTA) and nucleus accumbens (NAc), leaving individuals with a 
decreased sensitivity to pleasure in the absence of the drug. Specifically, regulation of 
DNA methyltransferases (to be discussed later) aid in the regulation of hippocampal 
plasticity (52). Given the complexity of these effects, a more in depth look at the role of 
epigenetics that is further impacted upon by drug use in the development of HAND is 
necessary. A detailed discussion on the significance of this phenomenon among the most 
commonly abused drugs is provided below. 
 
Cannabinoids  
Cannabis sativa, also known as marijuana, is one of the most commonly used drugs of 
abuse. It comprises over sixty cannabinoids, including cannabidiol, cannabinol, and Δ-9 
tetrahydrocannabinol (Δ-9-THC), which is the primary psychoactive ingredient. The 
mediator of the neuro-behavioral effects observed with the use of cannabis is the CB1 
receptor with operates primarily in the brain. The homologous CB2 receptor functions in 
the periphery and is found on the surface of immune cells, including T-cells and B-cells. 
Thus, HIV-infected patients using cannabis often experience epigenetic effects from 
immunomodulation, contributing to changes in HIV-1 progression (41).   
 
Epigenetic mechanisms associated with cannabinoid use 
The transcription factor ΔFosB, which is largely accepted as being an important 
component in the development of drug addiction, is generally activated in the presence of 
drugs of abuse, although the extent and location of its activity depends on the drug. 
Studies conducted on the effect of Δ-9-THC on ΔFosB activity involved the twice-daily 
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injection of Δ-9-THC into mice (53), which resulted in  ΔFosB induction prominently in 
the prefrontal cortex (54), the region of the brain known for decision-making, planning, 
and impulse control, implying that cognitive performance can most likely be affected. 
Besides this, no significant increase in ΔFosB activity was observed in the nuclear 
accumbens shell or dorsal striatum, which are instrumental in impulsivity and the ability 
to learn responses, respectively (55). Interestingly, increases were observed in these areas 
as a result of other drugs of abuse, namely cocaine, morphine, and ethanol.  
Studies on the impact of cannabinoids on epigenetic changes in fertility have been 
conducted, where cannabinoid receptor 1 (CNR1) null mutant mice displayed higher 
histone retention in germ cells compared to the wild type. CNR1 is important in 
spermiogenesis and helps to control the chromatin quality in the resulting sperm. The 
activation of this receptor mediates chromatin remodeling in spermatids by regulating 
transition protein 2 (Tnp2) levels or by increasing the level of histone displacement. Due 
to the fact that the use of exocannabinoids such as marijuana has been shown to cause 
lower fertility (56), it can be assumed that these can have the same observed effect as the 
endocannabinoids described in this study. Marijuana use is believed to deregulate the 
endogenous cannabinoid receptor system, which could potentially inhibit histone 
displacement during spermiogenesis, resulting in poor sperm quality, demonstrating the 
epigenetic ramifications of inactivating this receptor (56). 
 
Interactions between cannabinoids and HIV-1 
Cannabis use is common within the HIV-infected population because it is often 
considered a relatively low-risk drug useful for appetite stimulation in AIDS patients.  In 
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fact, Dronabinol, a synthetic form of Δ-9-THC, has been approved by the FDA to treat 
HIV-associated anorexia (57). In addition, one longitudinal study found no adverse 
effects of cannabis use on the CD4+ T-cell counts of HIV-positive men over the course of 
eleven years (7). 
The potential effects of cannabis use in HIV-1 infection have led to several studies 
albeit with conflicting observations. Cannabinoids have been shown to have an impact on 
cytokine production as well as lymphocyte function and survival (41). They also utilize a 
CB2 receptor-dependent pathway to regulate the balance and activation of human 
Th1/Th2 (T-helper) cells (58). HIV replication leads to the activation of the immune 
system, which causes an increase in pro-inflammatory cytokines, lymphocyte 
proliferation, and lymphocyte apoptosis (59). Molina et al. explored the effects of a 
month’s worth of regular injection of Δ-9-THC in rhesus macaques prior to simian 
immunodeficiency virus (SIV) infection (60), one of the best animal models for HIV 
studies. When plasma Δ-9-THC levels of the monkeys were maintained at 22 ng/mL, it 
resulted in decreased plasma and cerebrospinal fluid viral load as well as a lower level of 
tissue inflammation leading to a greater survival rate upon SIV infection. The ability of 
activation of the cannabinoid receptor to help suppress infection can be further seen in 
microglia where viral replication was inhibited by a synthetic nonselective CB1/CB2 
receptor agonist called WIN55,212-2 (61, 62).  In yet another study using SIV-infected 
rhesus macaques treated with Δ-9-THC, lower plasma and brain viral loads were 
observed compared to controls (41). These Δ-9-THC treated SIV-infected animals had 
lower levels of episomal SIV 2-long terminal repeat (2-LTR) DNA circles. These animals 
also displayed changes in the expression of 153 genes with several genes implicated in 
 13 
inflammation and HIV infectivity modulation. The decreases in tissue inflammation that 
have been observed with cannabis use in these studies, seemingly contribute to the 
decreases in virus replication. 
In contrast to these studies, it has been reported that cannabinoid receptor stimulation 
during HIV-1 infection can contribute to disease spread and pathogenesis. One study 
observed an increase in CCR5 and CXCR4 expression in peripheral blood leukocytes 
(PBLs) after ten days of Δ-9-THC administration (10 mg/kg) in immunodeficient mice 
along with an increase in HIV-infected cells (63). It has also been shown that when MT-2 
cells were cultured with cannabinoid agonists and infected with HIV, there is observably 
greater syncytia formation compared to cells exposed to HIV alone, implying that 
stimulation of the CB2 increased HIV-1 cytopathology and infection (64). Thus, 
regardless of consensus on the role of cannabinoid receptor stimulation on HIV-1 
infection, it is certain that epigenetic changes translate into apparent changes in disease 
progression as described above. 
Evidence of cannabinoids possessing the ability to elicit antiviral responses that 
manifest through DNA methylation is also present.  DNA methylation, an epigenetic 
mechanism that occurs as a result of exposure to cannabinoids, has been studied by a few 
groups, but the full mechanism has not yet been established. DNA methyltransferase 
(DNMT) activity has been shown to be increased when the p38 and p42/44 mitogen-
activated protein kinase (MAPK) pathways are activated by the CB1 receptor (65). This 
results in high levels of DNA methylation and, consequently, the inhibition of gene 
expression. Studies conducted on Δ-9-THC- exposed, SIV-infected animals showed that 
at least 50% of the differentially expressed genes that were found are involved in DNA 
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methylation (41). Some of these hypermethylated genes, such as CXCR4 and HIV-1 
enhancer binding protein (HIVEP1), play a role in the entry, production, and integration 
of the virus. These genes also affect inflammation and viral kinetics in the brain through 
the hypermethylation of CCAAT enhancer binding protein delta (C/EBPδ), which is 
involved in the mediation of IL-1 activation of NF-κB. Δ-9-THC exposure also affected 
the expression of miRNA in SIV-infected animals. Differentially expressed miRNA was 
found in CD4+ T-cells, intestinal mucosa, and the brain. The miR-21, which is generally 
upregulated during inflammatory conditions, was found to be downregulated in the brains 
of Δ-9-THC exposed, SIV-infected animals (41).  
 
Opioids  
Opioids are a class of drugs that act on the opioid receptors and induce symptoms such as 
respiratory depression, vomiting, depression of consciousness, and low blood pressure 
and pulse rate (66). Opioid users traditionally administer the drugs intravenously or 
through inhalation due to the rapid high that results. Heroin, a very common street drug 
that raises the risk of HIV transmission due to the possibility of sharing infected needles, 
breaks down into the active metabolite morphine in the body. Other examples of opioids 
that are abused include codeine, oxycodone, and methadone (66).  Due to the variety of 
opiates that an infected individual can take, it is important to study any epigenetic 
mechanisms that may affect disease progression in this group of drug users. 
 
Epigenetic mechanisms associated with opioid use 
Among all opioids, morphine has been the best studied with respect to its potential 
epigenetic effects. The μ-opioid receptor (MOR), which is primarily controlled by its 
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proximal promoter during neuronal expression, recruits HDAC1 and HDAC2. 
Additionally, MOR gene transcription increases in the presence of TSA, an HDAC 
inhibitor. This is thought to be due to the fact that TSA acetylates the local nucleosomes, 
allowing access to the necessary transcription factors (67). Some studies have been 
performed regarding the role that HDACs play in morphine-induced conditioned place 
preference (CPP), which is the tendency for addicted animals to prefer locations 
associated with drug administration. It was found that HDAC inhibition can aid in 
morphine-induced CPP extinction and attenuate reinstatement behavior, emphasizing the 
role that HDAC activity plays in the development of addiction (68). 
 
Interactions between opioids and HIV-1 
Opioid abuse has long been observed to exacerbate HIV-1 infection, particularly 
increasing the chances of neurological symptoms, due to its immunosuppressive effects, 
and constitutive production of proinflammatory cytokines that are known to alter blood-
brain barrier (BBB) permeability, as well as HIV-1-opioid interactions that cause 
inflammation and glial dysfunction (69). More specifically, it is thought that opioids 
amplify the effects of HIV-1 neurotoxicity by promoting apoptosis through the MOR 
(70). The OPRM1 (opioid receptor, mu 1) gene regulates MOR and is subject to many 
epigenetic changes. One such epigenetic mechanism is regulation of OPRM1 by Methyl-
CpG-binding protein 2 (MeCP2) using Brg1, a chromatin-remodeling factor, and DNA 
methyltransferase 1 (DNMT1) (71). The promoter’s CpG islands are methylated, 
allowing for MeCP2 binding. This leads to the recruitment of repressor proteins that 
facilitate the deacetylation of the relevant histones. It has already been established that 
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neuronal cells that do not express the OPRM1 promoter are methylated, while OPRM1-
expressing neuronal cells are not, confirming the importance of DNA methylation in the 
activation of this gene (72). In addition, former heroin addicts have been found to display 
hypermethylation of the OPRM1 promoter in the peripheral lymphocytes, regardless of 
whether or not they were HIV-infected, illustrating the epigenetic ramifications of long-
term use (73). SIV is further known to affect the OPRM1 promoter through DNA 
methylation in lymphocytes, although the exact mechanism is poorly understood (74). 
SIV infection increases DNMT activity, resulting in a methylated promoter, which blocks 
the initiation of the gene by preventing the Specificity protein 1 (Sp1) transcription factor 
from binding to the promoter at CpG island 1 and CpG island 2 (Fig. 1.2).  
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Fig. 1.2. Epigenetic changes to the OPRM1 promoter. DNMT activity increases upon 
the early stages of SIV infection, methylating the OPRM1 promoter at CpG island 1 and 
CpG island 2. This prevents the Sp1 transcription factor from initiating the gene, 
allowing the virus to remain latent in the lymphocytes in the presence of morphine.  
 
 It is believed that this activity increases the viability of the infected lymphocytes in 
the presence of morphine exposure. This phenomenon has only been observed in the 
early stages of infection, and it is believed that this allows the virus to remain latent in the 
cells for a longer period of time. Histone acetylation also plays an important role in the 
epigenetic effects of opioid use as HDAC1 and HDAC2 interact with the OPRM1 
promoter in neuronal NMB (neuroblastoma) cells. Additionally, TSA has also been found 
to impact OPRM1 gene expression, opening avenues for research on the effects that 
opioids have on chromatin accessibility (67).  
 Chronic morphine use has been shown to inhibit IL-2 secretion by activated T-cells 
via histone acetylation and trimethylation (75) and reducing CpG dinucleotide 
demethylation in the IL-2 promoter, thereby suggesting a strong link between morphine 
and changes in immune function. IL-2 therapy has been shown to aid in the survival of 
CD4+ T-cells during HIV infection (76), meaning that a reduction in IL-2 would have 
detrimental effects on these patients.  An increase in cAMP levels due to morphine 
exposure, leading to the upregulation of inducible cAMP early repressor (ICER) and 
cAMP response element modulator (CREM), has been shown to result in down 
regulation of CREB in activated T-cells (75). This causes CPB/p300, a chromatin-
remodeling complex, to uncouple and prevent IL-2 transcription. A decrease in acetylated 
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H3 and H4 binding, as well as reduced trimethylated H3K4 binding with regard to the IL-
2 promoter has also been observed (76).  
 
Cocaine 
Cocaine is an extremely addictive psychomotor stimulant that acts by inhibiting 
monoamine re-uptake by the presynaptic terminals. This extends the duration of their 
local anesthetic and vasoconstricting effects. Side effects include euphoria, stroke, 
ventricular arrhythmias, acute myocardial infarction, and renal and intestinal infarctions. 
It also hinders heat perception, leading to thermoregulatory adjustment impairment. 
Additionally, chronic use can lead the nasal septum to perforate. Cocaine can be taken 
intranasally, orally, or intravenously as it is a water-soluble powder (77). Intravenous 
injection leaves the cocaine users vulnerable to HIV infection due to the risk of using 
unsterile needles.  
  
Epigenetic mechanisms associated with cocaine use 
 Drug-induced alterations in the levels of histone acetylation in the brain are thought to 
play a role in drug addiction. While cocaine use often leads to greater H3 and H4 
acetylation in the nucleus accumbens (NAc), some genes display less histone acetylation 
after chronic cocaine exposure (11). The reason for this discrepancy is unknown, and 
further research is required. Various isoforms of HDAC have been shown to yield 
different responses in drug-exposed mice.  
       In fact, when animals were injected with Trichostatin A (TSA), a pan-HDAC 
inhibitor, in the NAc shell and then exposed to cocaine, they displayed elevated self-
administration rates and thus a greater level of addiction (78). It was also found that these 
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animals were willing to work harder for higher injection doses compared to the control 
animals. However, these results were unique to the NAc shell and were not observed 
when TSA was injected in to the NAc core or the medial prefrontal cortex. Further 
investigation confirmed that these observations were a result of increased H3 and H4 
histone acetylation leading to greater expression in the genes related to addictive 
behavior.  
 Chromatin immunoprecipitation studies were conducted on the BDNF (brain-derived 
neurotrophic factor) and Cdk5 (cyclin-dependent kinase 5) genes in order to determine 
what effect cocaine use has on their chromatin accessibility (79). BDNF plays an 
important role in synaptic plasticity, increasing the tendency to respond to cues that are 
related to natural rewards. Its continued expression during periods of withdrawal is 
thought to be related to the persistence of the cravings that define addiction. Both genes 
are known to be activated in response to chronic cocaine exposure. In this study, with 
chronic cocaine exposure, striking increases in H3 acetylation of the BDNF promoter 
were observed and persisted for a week after withdrawal. This is consistent with previous 
findings that BDNF protein levels increase during cocaine withdrawal (80). Although 
Cdk5 did not display the same persistence, another study has shown Cdk5 to play an 
important role in the mediation of dendritic arborization outgrowth in striatal neurons in 
response to chronic cocaine exposure (79). Chromatin immunoprecipitation assays 
confirmed chronic cocaine exposure increases ΔFOSB/Cdk5 gene promoter association, 
elucidating the previously unknown mechanism behind this observed phenomenon. Since 
the ΔFOSB promoter is already known to impact brain plasticity during addiction (79), 
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the association of Cdk5 with ΔFOSB strengthens the finding that Cdk5 affects the striatal 
neurons in this  manner. 
 Besides BDNF, tyrosine hydroxylase has been implicated as an important factor in 
cocaine-induced reward behavior. The mRNA levels of tyrosine hydroxylase were found 
to increase in the ventral midbrain upon exposure to a D1 agonist and the HDAC 
inhibitor, sodium butyrate, in cocaine-treated mice. This was determined to be the result 
of chromatin remodeling through H3 acetylation at the tyrosine hydroxylase promoter 
and the BDNF promoter of these regions (81).  
 One of the most widely studied transcription factors implicated in the epigenetic 
changes caused by drug abuse is ΔFOSB, the expression of which is increased in the 
chronic presence of drugs of abuse. This increase is most noticeable in the NAc and 
dorsal striatum in D1 dopamine receptor expressing medium spiny neurons (82). The 
overexpression of ΔFOSB has been shown to cause drug self-administration and 
increased impulsive behavior during withdrawal in mice. This is due to the large impact 
that ΔFOSB has on neuronal plasticity as a result of its regulation of various proteins 
associated with dendritic spine architecture, such as microtubule associated proteins, 
actin-related proteins, synaptotagmin, activity-regulated cytoskeleton-associated protein, 
kinesin, and cyclin-dependent kinase 5.  ΔFOSB is also involved in the regulation of 
proteins that are vital to glutamatergic synaptic function and plasticity, providing further 
evidence that this transcription factor has a large effect on the plasticity that is thought to 
contribute to drug addiction (11). One known mechanism by which ΔFOSB can have 
such a wide range of effects is by controlling nuclear factor-κB (NF-κB) levels in the 
NAc. NF-κB levels have been seen to increase in the presence of cocaine, contributing to 
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the increase in medium spiny neuron dendritic spine density that sensitizes the subject to 
the drug’s effects (83). 
Histone modifications at the cFos and FosB promoters have been studied due to their 
established responses to cocaine intake. Chromatin immunoprecipitation studies have 
shown that acute cocaine use results in H4 acetylation and H3 phosphoacetylation at the 
cFos promoter (79). These effects were observed 30 minutes after exposure and subsided 
after three hours with no relapse. However, chronic exposure to cocaine yielded different 
results. No changes in H4 acetylation or H3 phosphoacetylation were observed, showing 
that the induction of the cFos promoter is desensitized to the drug. While the response of 
the FosB promoter to acute cocaine exposure was very similar to that of the cFos 
promoter, its response to chronic cocaine ingestion differed due to an increase in H3 
acetylation. This difference was expected because FosB does not display the same level 
of desensitization that cFos does in protein studies. The same results were found when 
the rats being tested were allowed to self-administer the drug, showing that these 
epigenetic changes play a role in cocaine addiction. 
 FosB accumulation has been established in chronic cocaine exposure implicating its 
role in addiction-related behavior and the sensitization of animals to the drug response. 
CREB-binding protein (CBP) is a HAT that acetylates certain lysine residues and is 
recruited by CREB during cAMP-dependent PKA phosphorylation (84). CBP recruitment 
to the FosB promoter and H4 acetylation were found to increase in rodents that were 
injected with cocaine (84). In addition, suberoylanilide hydroxamic acid (SAHA), an 
HDAC inhibitor, was shown to induce an increase in FosB expression after cocaine 
exposure. No such effect was observed in animals that were not treated with cocaine, 
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reflecting the lack of FosB accumulation. The increase in FosB observed in the cocaine-
treated animals can be explained by SAHA’s inhibition of the deacetylation that would 
normally partially negate the effects of CBP. 
 Chronic cocaine use also suppresses striatal multiple myocyte-specific enhancer 
factor 2 (MEF-2) activity by way of D1 receptor cAMP dependent inhibition of 
calcineurin. MEF-2 binds to DNA recruiting coactivators such as p300 or corepressors 
including HDACs. It has recently been shown to regulate excitatory synapses suggesting 
the possibility for its role in addiction. MEF-2 is a substrate of Cdk5, which displays 
increased activity after chronic cocaine use. However, the exact role of MEF-2 in 
addiction is ambiguous because it causes an increase in medium spiny neuron dendritic 
spine numbers while also decreasing the subject’s behavioral sensitization to cocaine in 
some cases (11, 85). Recently, we identified a novel role for MEF-2 in the regulation of 
HTLV-1 LTR and subsequent viral infection (unpublished observations). 
 DNA methylation also seems to play an important role in cocaine addiction. Methyl 
CpG binding protein 2 (MeCP2) displays increased expression in the NAc and dorsal 
striatum in the presence of cocaine (11). Both acute and chronic cocaine exposure have 
been found to cause hypermethylation of the PP1c (protein phosphatase-1 catalytic 
subunit) promoter and hypomethylation at the fosB promoter. This was found in 
conjunction with increased DNMT3A and DNMT3B expression in the NAc. It is 
believed that MeCP2 aids in the recruitment of HDACs and histone methyltransferases to 
methylated PP1c promoters, resulting in increased CBP recruitment, and therefore, 
histone acetylation (86). 
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Interactions between cocaine and HIV-1  
Cocaine use plays a role in the neuropathogenesis of HIV-1 and can accelerate the 
development of HIVE (87). Cocaine increases the release of cytokines in immunoeffector 
cells and impairs macrophage and CD4+ T-cell function. The increased expression of 
inflammatory cytokines and endothelial adhesion molecules caused by cocaine leads to 
greater viral invasion and a higher incidence of cerebrovascular complications. Cocaine 
also increases interleukin-10 (IL-10) expression, which in some cases has been shown to 
promote HIV-1 replication in monocyte-derived macrophages in the presence of TNF-α 
(69), while in other studies IL-10 has been linked with inhibiting HIV-1 transcription 
(43). Cocaine promotes the activation of the virus in latently infected promonocytic U1 
cells, as evidenced by elevated levels of viral p24 protein. It activates the LTR through 
the mediation of NF-κB, which is essential for the transcription of the virus. The interplay 
between cocaine and HIV-1 is reviewed by Buch et al. (88), providing insight into the 
myriad of ways that the abuse of this drug aids in the progression of the disease.  
 HIV-1 is known to affect normal human astrocytes (NHA) when it enters the central 
nervous system (CNS), which usually occurs during the few days following infection. 
HIV replication in the CNS primarily occurs in the macrophage and microglial cells, 
although infection of the astrocytes has also been recorded. This leads to 
neuroimmunopathogenesis as the infected astrocytes spread the infection and cause 
damage to the surrounding cells. Cocaine use has been shown to enhance HIV-1 
replication in the NHAs through the upregulated HIV-LTR-R/U5 region (40). Cocaine-
exposed, HIV-infected NHAs also exhibited upregulated p24 antigen levels, indicative of 
high viral protein content. Cocaine exposure does affect HIV-1 replication in CD4+ T-
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cells and in peripheral blood mononuclear cells (89). It is believed that it impacts the 
entry of the virus, as well as the post entry steps that direct the replication of the virus. 
The proposed mechanism involves the downregulation of miR-125b, a microRNA 
involved in the differentiation of CD4+ T-cells, by cocaine, which enhances HIV 
replication. However, there is more work to be done in order to determine if there are any 
epigenetic mechanisms underlying these observed phenomena.  
 
Other miscellaneous drugs and their impact on epigenetics and/or HIV-1  
Alcoholism affects millions of Americans and their families. 30% of adults have engaged 
in alcohol abuse at least once, and the economic burden of alcoholism is around $400 
billion annually (90). Alcohol abuse symptoms often have epigenetic causes. The 
anxiolytic effects of acute alcohol ingestion occur in conjunction with the downregulation 
of HDAC activity and upregulation of H3/H4 acetylation and CBP. This process results 
in greater expression of Neuropeptide Y (NPY), an endogenous anxiolytic compound that 
has been implicated in the effects of ethanol, in the amygdala. The withdrawal effects that 
occur following chronic alcohol use have the opposite effect. Exposure to TSA following 
withdrawal from chronic alcohol use prevents these effects, leaving the amygdala with 
close to normal levels of acetylation (91). Alcohol use is common in the HIV-infected 
population, as evidenced by the fact that they are twice as likely to have a history of 
alcohol use than the general population and that almost half of HIV carriers report a 
history of alcohol abuse (92). Chronic alcohol consumption has been found to increase 
viral replication and upregulate proinflammatory cytokine production in HIV-positive 
patients (93). Individuals afflicted with both HIV and alcoholism show far greater brain 
abnormalities compared to those who are victim to one condition alone (94). Cognitive 
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deficiencies are also observed to occur more frequently within this population. However, 
not much is known about the epigenetic components of these observed phenomena.  
Amphetamines are another type of commonly abused drug and are considered to be 
stimulants, much like cocaine, but they remain in the CNS longer, increasing the duration 
of their effects (95). Amphetamines are also known to affect Th1/Th2 production in the 
murine model of AIDS (5). They impact epigenetics by mechanisms similar to those 
employed by cocaine. Acute exposure of amphetamines causes the induction of the c-fos 
and fosb genes in the NAc, which results in increased H4 acetylation on those gene 
promoters (4).  Recently, a connection between methamphetamine use, high-risk sexual 
behavior, and HIV transmission has been reported (96). Treatment with increasing doses 
of this drug correlated with altered glutamatergic function in the dorsal striatum of rats 
(97, 98). Epigenetic effects included an increase in recruitment of corepressor of RE1 
silencing transcription (CoREST), HDAC2, MeCP2, and sirtuin 2 (SIRT2) causing a 
downregulation of GluA1 and GluA2 mRNA levels upon methamphetamine treatment. 
Methamphetamine-induced increases in expression of genes such as Crf (major regulator 
of the pituitary-adrenal axis) in the NAc are associated with increases in histone H4K5 
and H4K8 acetylation whereas decreases in gene expression (ex. CCK; gene that encodes 
cholecystokinin neurotransmitter) correlate with hypoacetylation of histones (99). These 
changes are not effected immediately; rather they occur secondarily to 
methamphetamine-induced increases in ATF2 expression, resulting in altered gene 
expression in the NAc. In an HIV-1 transgenic rat model, oxidative stress caused by the 
combined and individual effects of HIV viral protein and low dose repeated 
methamphetamine exposure showed alterations in glutathion (GSH; the most abundant 
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antioxidant in the brain) content in both the thalamus and striatum in the brain depending 
on the type of exposure (100). In addition to this concerted effect by viral infection and 
drug use, exposure to both methamphetamine and supernatant from HIV infected 
monocyte-derived macrophages (MDM), dopaminergic neurons showed an increase in 
microRNA-9, -124 and let-7d, making the CNS neurons susceptible to drug tolerance and 
addiction (101). Individuals infected with HIV who use methamphetamines exhibit 
greater interneuron loss due to HIVE (102), as well as higher levels of reverse 
transcriptase activity in macrophages (103). Thus, the abuse of alcohol and/or 
amphetamines leave HIV-infected individuals vulnerable to exacerbated symptoms, 
many of which can likely be owed to epigenetic changes to the retroviral promoter, 
although the precise mechanisms are still being studied. 
 
Concluding notes 
There is still a great deal of work to be done in order to elucidate the epigenetic 
interactions between the previously discussed drugs of abuse and the LTR promoter. The 
need for this research is obvious given the high incidence of drug use within the HIV-
infected population. Extensive work has been done on the epigenetics of drug abuse 
within the context of addiction, proving that these drugs do in fact affect chromatin 
remodeling and DNA methylation. The next step is to investigate the extent to which 
these effects extend to the LTR, given that it is well known that there are many epigenetic 
factors that dictate the progression of HIV.  
 Drugs of abuse interact with HIV-1 in a variety of ways, many of them leading to 
similar end-point actions such as increased HIV-1 susceptibility and proinflammatory 
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cytokines to increases in CpG methylation and histone modifications (summarized in 
Figure 1.3).  
 
Fig. 1.3. Epigenetic effects of exposure to HIV-1 and drugs of abuse.  Cells in the 
brain or periphery that are exposed to HIV-1 and drugs of abuse undergo a variety of 
epigenetic changes.  Despite some of the differences in the pathways, many different 
drugs of abuse lead to similar end-point results in terms of epigenetic modifications.  (A) 
Exposure of cells to HIV-1 and various drugs of abuse such as cannabinoids, opioids, 
cocaine, alcohol, or amphetamines result in increased susceptibility to HIV-1 viral 
infection, and increases in proinflammatory cytokines, which can also exacerbate disease.  
(B) This exposure can also lead to epigenetic changes at the histone level allowing for 
DNA and genes of interest to be more or less available to host transcription factors and 
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transcriptional machinery.  The interaction of HIV-1 and drugs of abuse generally lead to 
an increase in chromatin modifying factors such as P300/CBP, p/CAF, and SWI/SWF.  
Additionally, use of alcohol, cocaine, amphetamines, or cannabinoids can lead to histone 
H3 and H4 acetylation through various pathways.  In contrast, signaling through MOR 
(µ-opioid receptor) by use of opioids can lead to HDAC1 and HDAC2 recruitment to the 
histones preventing gene transcription.  (C) These same drugs of abuse can also cause 
epigenetic changes at the DNA level potentially resulting in increases in MeCP2 and 
DMNT (DNA methyltransferase) recruitment to the DNA, depending on cell type, and 
leading to CpG methylation and prevention of specific gene expression.  
 
 Although these interactions are widely documented, there is uncertainty with respect 
to the epigenetic interactions between the drugs and the LTR. Given the heritability of 
certain epigenetic changes, it is possible that some of the modifications caused by the 
drug abuse in infected individuals could be passed on to the next generation, increasing 
their susceptibility to drug addiction. The relevance of this research is clear, and there is a 
great deal of evidence suggesting that there may be a larger link than previously believed. 
Studies conducted both in vitro and in vivo have confirmed that cannabinoids have an 
effect on HIV-1 in terms of DNA methylation and miRNA expression, highlighting the 
need for further investigation into the precise interactions that are occurring, especially 
with regard to the retroviral promoter. The implications of OPRM1 methylation during 
opioid abuse and its influence on HIV latency are vast and raise a lot of questions about 
whether there is direct effect on the viral promoter LTR as well. Given the extensive 
research on the epigenetic effects of cocaine use, it makes sense to explore the impact 
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that these effects may have on the retroviral promoter, especially since cocaine use is 
known to spur HIV replication. Applying an animal model similar those used in 
cannabinoid studies to cocaine studies is sure to elucidate the nature of the epigenetic 
interactions between the drug and the virus, giving way to refining treatment strategies 
for drug abusing, HIV-infected populations. Furthermore, alcohol, amphetamine, and 
methamphetamine abuse also exacerbate HIV symptoms through various means, both 
immunological and epigenetic. It is clear that drug abuse imparts epigenetic changes to 
the genome, and it is likely that similar effects are taking place on the LTR given the 
well-documented incidence of altered HIV replication in response to these drugs. 
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Chapter 2: Effect of cocaine on histone 
methylation at the retroviral promoter 
 
Introduction 
 
The importance of epigenetic changes with regard to HIV latency is well known. Histone 
3 lysine 9 di/tri-methylation (H3K9me2/3) is known to induce viral latency (47) and to be 
enriched in HIV-latent cells (104). This histone modification represses the surrounding 
genes and has been found to decrease upon viral activation (97). In fact, repressing H3K9 
methylation results in greater H3 acetylation as well as in LTR activation (100). 
Increased H3K27 methylation has also been observed in cells containing a latent provirus 
(101). Although H3K79 methylation, a histone modification associated with 
transcriptionally active chromatin regions, is known to be upregulated in certain cancers 
and to play a role in cell proliferation (96),  no work has been done to investigate H3K79 
methylation in the context of HIV. The inclusion of this histone modification was based 
on the fact that its presence would be expected to contrast that of the aforementioned 
heterochromatic markers. Since histone modifications can have an effect of viral latency, 
the next step was to see if cocaine exposure affects the T-cells vis-à-vis these specific 
methylation patterns.  
As discussed in Chapter 1, cocaine has been confirmed to impart epigenetic 
changes in both the CNS and the periphery, causing changes in brain plasticity, cytokine 
production, and HIV replication (69, 78, 89). The purpose of these experiments was to 
determine if cocaine exposure results in epigenetic changes on the HIV promoter in T-
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cells. FosB levels were also investigated due to the transcription factor’s role in cocaine 
addiction (53). Therefore, we first confirmed the presence of H3K9me2/3, H3K27me2, 
and H3K79me2 in the Jurkat T-cell line at the protein level using Western Blots. This 
was followed by a series of Chromatin Immunoprecipitation (ChIP) Assays to determine 
the abundance of each histone modification on the LTR itself.  
Materials & Methods 
 
Cell Culture 
The human T cell line, Jurkat (ATCC, TIB-152), was grown in RPMI-1640 media with 
L-glutamine supplemented with 10% heat-inactivated FBS, sodium bicarbonate (0.05%, 
Cellgro), and antibiotics (penicillin, streptomycin, and kanamycin at 0.04 mg/mL each, 
Cellgro).  The cells were maintained at a density between 1 x 105 and 1 x 106 cells/mL as 
recommended by ATCC.  All cells were maintained at 37°C in 5% CO2 at 90% relative 
humidity. 
Plasmid construction and site-directed mutagenesis 
The HIV-1 LAI LTR sequence was amplified by polymerase chain reaction (PCR) from 
previously published LAI-LTR-Luc reporter constructs (102, 103).  The following 
primers were used for the amplification of LAI LTR: 5’-GGC-CGG-ATT-AAT-TGG-
AAG -GGC-TAA-TTC-ACT-CC-3’ and 5’-GAC-CGG-TTG-CTA-GAG-ATT-TTC-
CAC-AC T-G-3’ (IDT). Following amplification, the HIV-1 LAI LTR was cloned into 
the pEGFP-N1 vector (Clontech), which contains the eGFP gene.  The PCR-product and 
the pEGFP-N1 vector were digested with the VspI (AseI) and the BshTI (AgeI) restriction 
enzymes and the digested PCR product was ligated into the digested pEGFP-N1 vector 
generating the LAI LTR-GFP reporter construct. The authenticity of the parental HIV-1 
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LTR construct was confirmed by DNA sequencing  (Genewiz). Sequences were analyzed 
using Lasergene software (DNASTAR, Inc.). 
Stable transfection of Jurkat cells and stably transfected cell clone 
development 
The HIV-1 LTR from the LAI backbone was cloned into pEGFP-N1 reporter vector 
(Clontech), replacing the existing CMV promoter, to drive GFP gene expression. Jurkat 
cells (ATCC) were transfected with the constructs using the AMAXA Nucleofector 
System and AMAXA Kit V (Lonza).  Transfected cells were passaged under 800 ng/mL 
G418 (Mediatech) selection beginning 24 hours after transfection for at least 8 weeks.   
Cell populations were each serially diluted to a final concentration of 1 cell/mL media 
and plated into 96 well plates.  Clonal cell populations were then propagated from each of 
the single cells for further study.   
Cocaine treatment of stably transfected cell clones and Western blotting 
Stably transfected cells (1.25 x 105 cells/mL) were exposed to cocaine hydrochloride 
(Sigma-Aldrich) at a concentration of 10-6M.  Cells were exposed to cocaine for 48 h and 
then harvested for further analysis.      
 Protein lysates were obtained from untreated, non-transfected Jurkat cells, 
cocaine-treated, non-transfected Jurkat cells, untreated LTR-transfected Jurkat cells, and 
cocaine-treated LTR-transfected Jurkat cells. Approximately, 10 x 106 cells from each 
group were incubated in 200uL of M-PER Mammalian Protein Extraction Reagent 
(Thermo Scientific) along with 10 uL/mL PIC and phosphatase for five minutes and then 
placed on ice and subjected to three freeze-thaw cycles. The concentrations of the 
resulting protein lysates were quantified using a Quick Start Bradford Protein Assay 
(Bio-Rad) per the manufacturer’s instructions. 30ug of each lysate was added to each 
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well of a 10% Tris-Glycine gel (Invitrogen) and blotted onto a PVDF membrane. The 
standard used was the SeeBlue Pre-Stained Standard (Invitrogen). The membranes were 
blocked with Odyssey blocking buffer (Li-Cor Biosciences) and probed with antibodies 
for H3, H3K79me2 (AbCam), H3K9me2/3, H3K27me2, and GAPDH (Cell Signaling 
Technology) followed by appropriately conjugated secondary antibodies. Signals were 
detected using the Odyssey infrared imager (Li-Cor Biosciences).  
 
ChIP Assay 
 
The cells were fixed and the chromatin isolated according to the ChIP-IT Express Kit 
(Active-Motif). Once the cells were grown to confluence, they were fixed with 37% 
formaldehyde and then washed with 1X phosphate buffered saline (PBS). The fixation 
was stopped by adding Glycine Stop-Fix Solution for 5 minutes and washing with PBS. 
The cells were then suspended in the provided Lysis Buffer supplemented with protease 
inhibitor cocktail and phenylmethylsulfonyl fluoride. The cells were transferred to an ice-
cold dounce homogenizer and subjected to ten strokes in order to release the nuclei. The 
lysed cells were pelleted, suspended in the provided Shearing Buffer, and sheared using a 
Sonicator Ultrasonic Processor XL (Heat Systems). The product was centrifuged for ten 
minutes at 15,000 rpm, and the resulting supernatant containing the sheared chromatin 
was subjected to IP. A portion of the sheared chromatin was use as input DNA that was 
suspended in the provided ChIP Buffer 2 and 5M NaCl. For IP, 20 ug of chromatin was 
added to the provided Protein G Magnetic Beads, ChIP Buffer 1, PIC, and 2 ug of the 
appropriate antibody and incubated in an end-to-end rotator at 4°C overnight. The 
antibodies used were the provided RNA Polymerase II antibody (Active-Motif), Di/Tri-
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Methyl-Histone H3 (Lys9) (6F12), Di-Methyl Histone H3 (Lys27) (D18C8) (both from 
Cell Signaling Technologies), Anti-Histone H3 (methyl (di) K79) (ab3594) (Abcam), 
FosB (5G4), and Mouse (G3A1) IgG1 Isotype control (Cell Signaling). Following the 
overnight incubation, the tubes containing the reactions were placed in a magnetic stand 
so that the beads would pellet against the side of the tube. The supernatant was discarded, 
and the pellet was washed once with ChIP Buffer 1 and twice with ChIP Buffer 2. The 
washed beads were suspended in the provided Elution Buffer AM2 and incubated at 
room temperature for 15 minutes. The provided Reverse-Cross-linking Buffer was added 
to the eluted chromatin, and supernatant containing the chromatin was transferred to a 
fresh tube. The ChIP and input DNA samples were incubated at 95°C for 15 minutes 
before adding the provided Proteinase K. They were then incubated at 37°C for 1 hour. 
The provided Proteinase K Stop Solution was added following the incubation, and the 
resulting DNA was subjected to Real-Time PCR. 
Real-Time PCR 
 
A standard curve was generated by performing five ten-fold serial dilutions (0.005-50 ng) 
of the input DNA for each sample. Reactions were performed in duplicate using 10uL 
SYBR Green PCR Master Mix (Applied Biosystems), 10uM each of forward and reverse 
primers (IDT), and 6 uL of the ChIP sample to a total volume of 20uL. The Real-Time 
PCR was performed using a LightCycler 480 System (Roche) with thermal cycling 
conditions comprising an initial activation step at 95°C for 10 minutes followed by 40 
cycles including a 15 second denaturation period at 95°C and annealing and extension for 
1 minute at 60°C. The following primers were used for the HIV-1 LTR: (F: 5’-AGCCCT 
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CAGATGCTGCATAT-3’, R: 5’-GGGCACACACTACTTGAAGC-3’). The resulting Ct 
values were used to calculate fold enrichment.  
Fold Enrichment Calculation 
 
The dilution curve was plotted on a log scale so that the linear curve could be determined. 
The amplification efficiency (AE) was calculated using the slope of the aforementioned 
curve. The percent of ChIP DNA and the percent of IgG DNA were calculated by 
subtracting the appropriate Ct values from the input Ct value most closely resembling 
that of the protein of interest and compensating with the corresponding dilution factor 
(FD). The percent ChIP was divided by the percent IgG to determine the fold enrichment. 
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Results and Discussion 
 
While a majority of published literature is focused on cocaine’s effects on brain cells 
and/or NeuroAIDS, not much is known about the epigenetic effects of cocaine in the 
periphery. Therefore, the purpose of this study was to investigate whether cocaine 
treatment causes any changes in histone methylation patterns of the proviral long terminal 
repeat (LTR) region integrated in Jurkat cells (a lymphoblastoid cell line). Specific 
modifications (mentioned above) on histone H3 were identified at the protein level (using 
western blot) and then at the DNA level (using ChIP assay). 
 
Confirming of the presence of histone modifications through Western 
Blot 
In order to confirm whether or not H3K9me2/3, H3K27me2, and H3K79me2 were 
present and detectable in the Jurkat cells, a series of western blots were performed. The 
goal was to detect these modifications at the protein level in both untreated and cocaine-
treated Jurkat cells without and with LTR. GAPDH and total H3 were used as controls. 
All of the relevant proteins were detected (Fig. 2.1 A). Based on densitometric analysis 
(normalized to GAPDH), there was a modest decrease in H3K9me2/3 upon cocaine 
treatment, but the difference was not statistically significant. The same was the case when 
the density values were further normalized to total H3. Upon H3 normalization, a 
decrease in H3K79me2 and H3K27me2 was observed following cocaine treatment in 
non-transfected Jurkat cells, while an increase in H3K79me2 occurred in the LTR-
transfected samples. The decrease in H3K27me2 was consistent in both cases (Fig. 2.1 
B).  
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H3K9me2/3, H3K27me2, and H3K79me2 were all detected at the protein level in 
untreated and cocaine-treated Jurkat cells (untransfected as well as stably transfected with 
viral LTR), confirming that these modifications do indeed occur in the Jurkat cells. 
Although there were slight changes at the protein level, they were not statistically 
significant, indicating that there is some effect on the histone variation although the 
extent is difficult to ascertain through protein alone. In addition, these results do not 
reflect changes specific to the LTR.  
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Figure 2.1. Detecting histone modifications in control and LTR-transfected Jurkat 
cells (without and with cocaine treatment). A) Images are given from the 
representative experiments. B) Densitometric analyses were performed using ImageJ 
software and normalized to both GAPDH and total H3.  
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Investigating epigenetic changes at the histone levels using ChIP Assay 
 
DNA and protein were first cross-linked using formaldehyde before lysing the cells and 
shearing the DNA through sonication. The resulting sheared chromatin was then 
subjected to immunoprecipitation using antibodies for the histone modifications of 
interest, RNA Polymerase II, a positive control, and IgG, a negative control. Magnetic 
beads were used to capture the antibody-bound chromatin, which was then subjected to 
reverse-crosslinking and Proteinase K digestion. The cross-links were then reversed so 
that the DNA could be subjected to Real-Time PCR with the goal of determining the fold 
enrichment (Fig. 2.2 A). The fold enrichment was calculated using the slope of the 
standard curve (Fig. 2.2 B). The method and calculations were validated by measuring 
global H3K9me2/3 levels in Jurkat cells compared to global RNA Polymerase II levels. 
The Real-Time PCR was performed using the human alpha-satellite repeat primer, which 
detects H3K9me2/3 throughout the genome. The H3K9me2/3 levels far exceeded the 
RNA Polymerase II levels throughout the cells’ genome (Fig. 2.2 C). 
The results of the ChIP Assay showed changes in methylation patterns with 
greater sensitivity. Although the increase in H3K9me2/3 on the LTR was modest, its 
increase across the cells’ genome was profound and indicated that cocaine does have 
global epigenetic effects that may impact cell function, as is suggested by literature. As 
discussed above, it is well established that cocaine use affects T-cell functions in a 
number of ways, and this study suggests that changes in histone methylation may be a 
significant contributor to that. Although H3K9me2/3 did not show much change on the 
LTR itself, its global upregulation indicates that it may cause phenotypic changes in T-
cells that could impact HIV latency and proliferation in another way. The next step would 
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be to conduct further studies to determine which genes are being methylated and what 
their effects would be.  
The significant increase in H3K27me2 on the LTR implies that this histone 
modification may play a larger role in the regulation of the retroviral promoter and that 
has sensitivity to cocaine. Higher H3K27me2 indicates decreased gene expression on that 
locus, which was confirmed by the decrease in RNA Polymerase II. The observed 
increases in H3K9me2/3 and H3K27me2, both of which are associated with reduced gene 
expression, and the decreases in RNA Polymerase II and H3K79me2, which indicate high 
gene expression, suggest that cocaine treatment results in repression of this segment of 
the LTR, possibly contributing to viral latency. An increase in viral latency could hamper 
highly active antiretroviral therapy (HAART) by preventing the total elimination of HIV 
reservoirs (104). Given the high incidence of cocaine use among the HIV-infected 
population (7), this presents a problem, as the rate of AIDS within this population is 
likely to increase over time. However, understanding the epigenetic components 
underlying the increase in latency could allow for treatment regimens consisting of 
histone methyltransferase (HMT) inhibitors, which would prevent the undesired increase 
in histone methylation.  
Furthermore, significant changes in all three of the studied histone modifications 
occurred throughout the genome based on the Real-Time PCR performed using the 
human alpha-satellite repeat primers (Fig. 2.3 B). The decrease in RNA Polymerase II 
was consistent with the findings on the LTR, while H3K79me2 levels increased. This 
increase in global methylation suggests that cocaine increases histone methylation 
throughout the genome, but that restrictive modifications occur at a higher rate than those 
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that are associated with gene expression. Furthermore, the primers used amplified 
multiple regions throughout the genome, each of which may have experienced different 
levels of expression upon cocaine treatment. Further sequencing studies could be used to 
confirm this.  
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Figure 2.2. ChIP Assay Schematic and Optimization. A) Overview of the ChIP Assay. 
B) Description of fold enrichment calculations. C) Global H3K9me2/3 and RNA Pol II 
fold enrichment in Jurkat cells based on human alpha-satellite repeat primer.  
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Once the assay had been optimized, the next step was to process the untreated and 
cocaine-treated LTR-transfected samples in the context of the retroviral promoter. When 
the LTR primer was used, a consistent decrease in RNA Polymerase II was observed 
upon cocaine treatment. H3K9me2/3 showed a modest increase in the cocaine-treated 
cells, while H3K27me2 increased significantly (p<0.05). In contrast, H3K79me2 
decreased following cocaine exposure though its fold enrichment varied among the 
experiments. When H3K9me2/3 levels were measured using the human alpha-satellite 
repeat primer, a drastic increase occurred in the cocaine-treated samples. Global RNA 
Polymerase II levels also decreased as they did when the studies were performed using 
the LTR primer. The increase in H3K27me2 was significant both on the LTR and 
globally, indicating that cocaine does have a profound effect on this particular chromatin 
modification, the implications of which should be investigated further.  
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Figure 2.3. Cocaine treatment results in histone modifications in LTR-transfected 
Jurkat cells. A) Real-Time PCR performed on untreated and cocaine-treated LTR-
transfected Jurkat cells using the LTR primer showed various histone modifications. 
Experiments were performed in duplicate with values presented as average plus standard 
deviation. B) Real-Time PCR was performed on LTR-transfected Jurkat cells using the 
human alpha-satellite repeat primer in order to measure global histone methylation and 
RNA Polymerase II binding.  
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The relative levels of the transcription factor, FosB, were also measured with 
regard to the LTR given the known importance of FosB in cocaine addiction. The binding 
of FosB to the LTR decreased upon cocaine treatment, a finding that is consistent with 
the decrease in transcription observed in previous experiments. However, FosB binding 
increased throughout the genome upon cocaine treatment to an insignificant extent, 
indicating that there is some upregulation of FosB expression similar to what is observed 
in the CNS, but that the effects are not as pronounced in the periphery. Although the role 
of FosB in cocaine addiction is clear in the context of the central nervous system, its role 
in the periphery has not been elucidated. The next steps would be to determine if there are 
any physiological changes that occur as a result of the increase in FosB activity. 
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Figure 2.4. Fold enrichment of FosB decreases in LTR-transfected Jurkat cells upon 
cocaine treatment. Real-Time PCR was performed in duplicate on FosB-
immunoprecipitated cells using the LTR primer.  
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Concluding remarks  
 
Knowing that histone methylation on the LTR is affected by cocaine use opens up new 
avenues for research in histone acetylation, DNA methylation, microRNAs, and other 
epigenetic factors. Elucidating the exact mechanisms through which cocaine alters the 
expression of the virus could help with the development of new treatment strategies for 
HIV-infected drug users. Cocaine causes global changes throughout the T-cells that 
manifest in a variety of ways. As shown, there are various epigenetic changes that occur, 
and there are various phenotypic changes as well. The expression of adhesion molecules 
can be impacted by drug use, causing changes in disease progression with regard to HIV-
1. A method for determining the extent of T-cell adhesion to the blood brain barrier was 
developed in order to quantify the degree to which drug exposure affects this 
phenomenon.  
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Chapter 3: Designing a flow chamber 
to measure lymphocyte adhesion to a 
blood-brain barrier model 
 
Introduction 
Cocaine use plays a role in the neuropathogenesis of HIV-1 and can accelerate the 
development of HIV encephalopathy (HIVE) (87). Cocaine increases the release of 
cytokines in immunoeffector cells and impairs macrophage and CD4+ T-cell function. 
The increased expression of inflammatory cytokines and endothelial adhesion molecules 
caused by cocaine leads to greater viral invasion and a higher incidence of 
cerebrovascular complications. Cocaine also increases interleukin-10 (IL-10) expression, 
which in some cases has been shown to promote HIV-1 replication in monocyte-derived 
macrophages in the presence of TNF-α (69) 
Cocaine use is known to enhance leukocyte migration as evidenced by the 
increased infiltration of mononuclear blood cells into the blood vessels of the brain (105). 
The drug upregulates endothelial adhesion molecules, causing increased leukocyte 
transmigration across the blood-brain barrier (BBB). Rats that were exposed to chronic 
doses of cocaine also experienced greater white blood cell rolling flux as well as greater 
leukocyte-endothelial cell adhesion. Cocaine specifically increases VCAM-1 expression. 
VCAM-1 is involved in peripheral blood lymphocyte adherence to endothelial cells and 
displays an increase in brain endothelial expression in AIDS patients, allowing the virus 
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to enter the CNS via the monocytes. Furthermore, cocaine increases the BBB’s 
permeability, allowing small molecules to enter the CNS more readily (105).  
 Treating hCMECs, a well-established in vitro BBB model, with cocaine results in 
greater adhesion and transmigration of monocytes (99). The next step would be to 
replicate these results under physiologic blood flow conditions through the use of a 
laminar flow assay (106). A parallel-plate flow chamber allows the user to subject the 
cells to various shear stresses in order to mimic the conditions found in the endothelium, 
while observing the fluorescently stained blood cells in real time (Fig. 3.1)   
Using a laminar flow assay rather than a simple adhesion assay has several 
advantages. The laminar flow assay can be completed in a few minutes, while traditional 
adhesion assays can have long incubation times. In addition, some adhesion events are 
impossible to characterize under static conditions because they only occur in the presence 
of shear stress. Visualizing these events also allows for the observation of specific 
behaviors, such as migration, rolling, tethering, and spreading (107).  
 The goal was to develop a flow chamber for use in a laminar flow assay that 
allows for real time visualization of adhesion events between hcMECS and primary 
peripheral blood lymphocytes (PBLs). An ideal flow chamber would be reusable, 
compatible with the relevant cell cultures, and capable of withstanding the necessary 
shear stresses, while also allowing for the successful imaging of the adhesion events.  
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Figure 3.1 Schematic of the laminar flow assay. The set up of the laminar flow assay is 
based on this illustration. 
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Materials & Methods 
Cell Culture 
The hcMEC/D3 cell line was obtained from Dr. Pierre-Olivier Courard (Institut Cochin, 
France) and maintained in EBM-2 Basal Medium (Lonza) supplemented with 2.5% fetal 
bovine serum (FBS), hydrocortisone, ascorbic acid, and VEGF. Peripheral blood 
lymphocytes were isolated from the buffy coat of healthy donors through Ficoll-Paque 
Plus (Amersham Biosciences) density gradient centrifugation. Monocytes were left to 
adhere to the bottom of tissue culture plates, while PBLs were separated by washing and 
then cultured in RPMI supplemented with FBS and IL-2. The isolated PBLs were stained 
for 30 minutes using Calcein AM (Invitrogen) at a concentration of 5 uL/mL and washed 
twice with PBS.  
Laminar Flow Assay 
The hcMEC/D3 cells were grown to confluence on glass slides that had been coated in 
50ug/uL rat collagen (Sigma-Aldrich). The cell-coated slide was placed into the flow 
chamber, which was then sealed and hooked up to a Harvard Apparatus Model 77 
Peristaltic Pump at the inlet using silicon tubing. The outlet was attached to tubing that 
allowed fluid to flow into a waste beaker.  
The shear stress (Wst) was calculated using the following equation: 
𝑊𝑠𝑡 = 6𝜇𝑄𝑎2𝑏  
The estimated viscosity of the fluid being used is denoted as μ, Q is the volumetric flow 
rate, a is the channel height, and b is the channel width. The entrance length (L) was 
calculated using: 
𝐿 = 0.06𝜌𝑄ℎ
𝑏𝜇
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In this case, ρ represents the density of the fluid, h is the height of the flow chamber, and 
the remaining variables are the same as the previous equation. Approximately 50 x 106 
fluorescently labeled PBLs were allowed to flow through the flow chamber while 
suspended in PBS (μ=0.0105 P).  
Imaging was performed using a Zeiss Axiovert 40 CFL microscope. Images were 
processed using ImageJ software with a Manual Tracking plug-in.  
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Results and Discussion 
The laminar flow assay was first performed using a flow chamber designed by Mr. Rob 
Yucha. Based on this first attempt, modifications were made so that a flow chamber 
could be designed for this specific application.  
First Attempt 
The laminar flow assay was first performed using Mr. Yucha’s design with an inner 
chamber with the following working dimensions: 25 mm x 75mm x 1.59 mm. The 
exterior of the chamber was 90 mm x 188 mm. The top plate was 4.45 mm thick, and the 
bottom plate was 12.7 mm thick. This flow chamber was designed for other applications, 
but was used as a model. The peristaltic pump was set to 25 mL/min, resulting in a shear 
stress of 0.25 dynes/cm2.  The endothelial cells remained intact at this flow rate, showing 
that this is a viable method for performing live cell imaging. The PBLs were observed 
flowing over the endothelial cells at a constant rate, which showed that the peristaltic 
pump and the flow chamber were capable of producing adequate laminar flow (Fig 3.2).  
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Figure 3.2. PBLs flowing over endothelial cells during first attempt. Images were 
taken at 10X and show that the endothelial cells were in tact throughout the experiment. 
PBLs can be seen migrating over the hcMEC/D3s although no adhesion events are 
observed. 
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However, the flow chamber accommodated a slide with measurements of 5 cm x 
7.5 cm, making the process of growing the hcMEC/D3s to confluence inconvenient. In 
addition, the adhesion events were observed using this flow chamber, indicating that it 
may have been too deep, not allowing the PBLs to react with the endothelial cells. 
Images were taken using bright field microscopy in order to convey the presence of both 
endothelial cells and PBLs.  
 
Second Attempt 
Based on the obstacles encountered during the previous experiment, a new flow chamber 
was constructed based on a modified design. The material of choice was acrylic based on 
its transparency and ease of use. The external dimensions of the flow chamber were 
unaltered, while the bottom plate was modified with an insert designed to accommodate a 
standard 75 mm x 25 mm x 1.0 mm glass microscope slide (Fisher Scientific) (Fig. 3.3 
A). This allowed the cells to be conveniently cultured inside of a tissue culture dish. The 
top plate was modified so that the chamber would be 1.0 mm with the intention of 
creating a more shallow space for the PBLs and the endothelial cells to interact (Fig 3.3 
C). The top and bottom plates were sealed together with twelve screws and an O-ring in 
order to prevent leaks (Fig 3.3 B).  
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Figure 3.3. Modified Design. A) Drawing of the modified flow chamber B) Photograph 
of the sealed flow chamber with a cell-coated slide inside C) Primary design 
modification, which would allow for greater cell interaction 
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The laminar flow assay was repeated using the same procedure described above with the 
exception of the flow rate, which was changed to 10 mL/min in order to achieve a shear 
stress of 0.25 dynes/cm2. Fluorescent images were taken at a frame rate of 6.33 seconds 
at three different visual fields and processed using the Manual Tracker plug-in for 
ImageJ. This can be used to quantify the number of adherence events compared to how 
many cells are introduced into the assay. Given that the entrance length of the flow 
chamber was calculated to be 0.038 cm, it is recommended that images be taken past this 
point in order to ensure that laminar flow has been reached. Furthermore, since the 
peristaltic pump used allows for flow rates ranging from 0.01 mL/min to 700 mL/min, 
this laminar flow assay is able to produce shear stresses from 4.2 x 10-4 dynes.cm2 to 29.4 
dynes/cm2. Adhesion events (designated with the white arrows) were observed based on 
the fluorescent images (Fig. 3.4).  
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Figure 3.4. Fluorescent images of the PBLs at a flow rate of 10 mL/min. Images were 
taken at a frame rate of 6.33 seconds using a 10X objective.  
Stationary cells clearly can be seen in contrast to the cells that are flowing over 
the endothelial layer without adhering. The paths taken by the non-adhering PBLs can 
also be seen using Manual Tracker (Fig. 3.5).  
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Figure 3.5. Representation of cell migration using Manual Tracker. Successive 
images from two fields of view (A & B) were used to construct these renderings of the 
paths taken by the non-adhering PBLs.  
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The laminar flow assay can then be used to determine the effect that cocaine 
exposure has on T-cell transmigration through the BBB by treating the PBLs, endothelial 
cells, or both with cocaine and comparing the number of resulting adhesion events. 
Similar studies could be performed using different cell types, such as monocytes or 
dendritic cells, and also using other drugs of abuse, such as opiates or cannabinoids. 
Since the flow chamber is reusable, it is possible to run multiple samples in succession 
given that the appropriate cells have been grown on multiple slides. Furthermore, using 
the tracking information given by the Manual Tracker plug in, it is possible to quantify 
the velocity and distance traveled by the cells in order to determine the phenotypic 
characteristics (adhesion, rolling, crawling) of the PBLs (108).  
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